Caribou Biosciences Inc (CRBU)
1.76
-0.11
(-5.88%)
USD |
NASDAQ |
Jun 25, 16:00
1.75
-0.01
(-0.57%)
After-Hours: 20:00
Caribou Biosciences Shareholders Equity (Quarterly): 343.29M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 343.29M |
| December 31, 2023 | 368.40M |
| September 30, 2023 | 398.27M |
| June 30, 2023 | 269.46M |
| March 31, 2023 | 278.27M |
| December 31, 2022 | 300.87M |
| September 30, 2022 | 324.11M |
| Date | Value |
|---|---|
| June 30, 2022 | 347.89M |
| March 31, 2022 | 371.80M |
| December 31, 2021 | 387.82M |
| September 30, 2021 | 404.40M |
| June 30, 2021 | -47.69M |
| March 31, 2021 | -35.69M |
| December 31, 2020 | -23.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.69M
Minimum
Jun 2021
404.40M
Maximum
Sep 2021
263.41M
Average
333.70M
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 26.99B |
| Sangamo Therapeutics Inc | 56.70M |
| Vertex Pharmaceuticals Inc | 18.55B |
| Bio-Path Holdings Inc | -2.625M |
| Revance Therapeutics Inc | -98.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 406.82M |
| Total Liabilities (Quarterly) | 63.54M |
| Current Ratio | 10.49 |